使用本網站需要啟用 JavaScript, 請啟用后刷新頁面獲得更好的體驗
亚洲精品午夜精品,日本二手网站,国产AⅤ爽AV久久久久成人社区,日本一二三区不收费av
<dfn id="cn9qa"><li id="cn9qa"><code id="cn9qa"></code></li></dfn>
登錄
注冊
首頁
個人基因檢測
臨床應用研究
科研合作項目
合作與服務
社區
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
使用 WeGene 需要啟用 Cookies, 請啟用后刷新頁面獲得更好的體驗
社區首頁
小組
2型糖尿病
2型糖尿病
發起討論
2型糖尿病
28 個討論
只看精華帖
按熱門排序
按最新排序
我的十萬有99999是怎么回事
ccdebeiai
? 最后回復
z6630162
?
2017-10-24 09:52
3714
7
? 來自相關小組
我血糖耐受受損，餐前約6.8，餐后約10，糖化約6.4，己經用藥2年了，糖尿病風險竟然才0.34，是不是吃藥引起誤差?
luoguoan
? 2017-08-29 17:25
3266
0
? 來自相關小組
二型糖尿病4.16倍
行走的3號染色體
? 2017-08-26 00:29
2648
0
? 來自相關小組
2型糖尿病8.44倍…
小只的6號染色體
? 最后回復
nnlory
?
2017-08-22 18:27
3259
2
? 來自相關小組
如果攜帶2型糖尿病的基因，還需要了解哪些相關基因問題會更加有幫助？
WendySugus
? 最后回復
yaoxt
?
2017-07-25 15:57
4025
3
? 來自相關小組
沒有家族糖尿病史為何糖尿病風險高
豁達的IMPG1基因
? 最后回復
賣萌的GBA3基因
?
2017-07-18 17:15
4099
6
? 來自相關小組
是否可以有二型糖尿病的基因數據呢
朱屹
? 最后回復
朱屹
?
2017-03-21 10:59
3294
2
? 來自相關小組
報告更新后，感覺整個人都不好了
粗眉的SNX29基因
? 最后回復
費力科思
?
2016-12-20 05:26
4427
1
? 來自相關小組
<
1
2
發起討論
2型糖尿病
28 個討論
相關基因
WFS1
位點：RS10012946
NRXN3
位點：RS10146997
TMEM258
位點：RS102275
SUGP1
位點：RS10401969
SDHAF4
位點：RS1048886
RNF6
位點：RS10507349
MTNR1B
位點：RS10830963
GRK5
位點：RS10886471
NOTCH2
位點：RS10923931
CHUK
位點：RS11591741
FTO
位點：RS11642841
位點：RS8050136
位點：RS9939609
ADCY5
位點：RS11708067
SLC16A11
位點：RS117767867
GPSM1
位點：RS11787792
TCF7L2
位點：RS12255372
位點：RS4506565
位點：RS7903146
BCL2
位點：RS12454712
ZMIZ1
位點：RS12571751
SLC30A8
位點：RS13266634
位點：RS3802177
IGF2BP2
位點：RS1470579
位點：RS4402960
RPSAP52
位點：RS1531343
KCNK16
位點：RS1535500
ARAP1
位點：RS1552224
TOMM40
位點：RS157582
ST6GAL1
位點：RS16861329
DGKB
位點：RS17168486
PTPRD
位點：RS17584499
GCK
位點：RS1799884
PPARG
位點：RS1801282
VPS26A
位點：RS1802295
AP3S2
位點：RS2028299
TFAP2B
位點：RS2206277
KCNQ1
位點：RS2237892
位點：RS2237895
位點：RS2237897
TRIB3
位點：RS2295490
MRAS
位點：RS2306374
POC5
位點：RS2307111
KCNQ1OT1
位點：RS231362
CMIP
位點：RS2925979
TEX14
位點：RS302864
POU5F1
位點：RS3130501
LPL
位點：RS328
PROX1-AS1
位點：RS340874
DYRK1B
位點：RS367643250
PEPD
位點：RS3786897
位點：RS10425678
MTTP
位點：RS3816873
SRR
位點：RS391300
ZBED3-AS1
位點：RS4457053
ADAMTS9-AS2
位點：RS4607103
CDKAL1
位點：RS4712523
位點：RS7756992
位點：RS9465871
HNF4A
位點：RS4812829
ANK1
位點：RS516946
KCNJ11
位點：RS5219
MAEA
位點：RS6815464
ARL15
位點：RS702634
GLIS3
位點：RS7041847
HMG20A
位點：RS7178572
PNPLA3
位點：RS738409
RASGRP1
位點：RS7403531
HNF1B
位點：RS757210
位點：RS11651052
CEP68
位點：RS7572857
THADA
位點：RS7578597
RBMS1
位點：RS7593730
GCKR
位點：RS780094
PRC1-AS1
位點：RS8042680
位點：RS2290203
JAZF1
位點：RS864745
TP53INP1
位點：RS896854
ZFAND3
位點：RS9470794
SGCG
位點：RS9552911
MACF1
位點：RS2296172
KIF9
位點：RS2276853
ACSL1
位點：RS60780116
JADE2
位點：RS329122
SSR1
位點：RS9505118
UBE3C
位點：RS1182436
位點：RS1182389
BRAF
位點：RS9648716
PLEKHA1
位點：RS2292626
HSD17B12
位點：RS1061810
WSCD2
位點：RS3764002
ABCB9
位點：RS4275659
FAM234A
位點：RS9940149
BPTF
位點：RS12602912
MLX
位點：RS665268
ZZEF1
位點：RS7224685
GLP2R
位點：RS78761021
ZHX3
位點：RS17265513
PTGFRN
位點：RS1127655
PTH1R
位點：RS11926707
MBNL1
位點：RS4472028
SCD5
位點：RS993380
YTHDC2
位點：RS10077431
CTTNBP2
位點：RS13239186
RELN
位點：RS2299383
ZNF34
位點：RS2294120
USP3
位點：RS982077
EYA2
位點：RS6066138
SAMM50
位點：RS4823182
GRB14
位點：RS75536691
PSMD6
位點：RS3816157
MIR548AC
位點：RS1496653
FSCN3
位點：RS806215
PAX4
位點：RS2233580
ETS1
位點：RS11819995
GP2
位點：RS117267808
NFATC2
位點：RS6021276
Replication of the association between variants in the WFS1 gene and risk of type 2 diabetes in European populations
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
Replication of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan - See more at: http://press.endocrine.org/doi/10.1210/jc.2008-0452?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&#sthash.tkccZ0hT.dpuf
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study)
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
The TRIB3 Q84R Polymorphism and Risk of Early-Onset Type 2 Diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A form of the metabolic syndrome associated with mutations in DYRK1B.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
查看參考文獻
首頁
個人基因檢測
臨床應用研究
科研合作項目
合作與服務
示例報告
下載 APP
社區
關于 WeGene
關于我們
媒體新聞
倫理委員會
隱私協議
加入我們
服務協議
價格保護
幫助中心
關于基因檢測
賬戶購買
樣本寄送
報告解讀
隱私安全
關于第三方數據
社區分享
開放平臺
申請成為開發者
開發文檔
客服微信公眾號
聯系我們
客服郵箱：
[email protected]
合作咨詢：
[email protected]
© 2025 WeGene. All Rights Reserved
深圳市市場監督管理局企業主體身份公示
|
粵ICP備15012185號
| 互聯網藥品信息服務資格證書:（粵）-非經營性-2023-0379
中文
English
<track id="ffr4e"></track>
<dfn id="ffr4e"></dfn>
主站蜘蛛池模板：
平潭县
|
枣阳市
|
高阳县
|
内丘县
|
平原县
|
凌云县
|
宿松县
|
博客
|
榕江县
|
郑州市
|
新干县
|
庆城县
|
扎鲁特旗
|
基隆市
|
利辛县
|
望谟县
|
白山市
|
伊宁县
|
体育
|
宣城市
|
襄城县
|
京山县
|
山东省
|
突泉县
|
奎屯市
|
潞西市
|
新蔡县
|
漳州市
|
页游
|
岗巴县
|
清水河县
|
满洲里市
|
台江县
|
东乌珠穆沁旗
|
大厂
|
垦利县
|
怀化市
|
安宁市
|
西和县
|
甘洛县
|
柘城县
|
<center id="vez93"></center>
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
深圳市市場監督管理局企業主體身份公示
中文
English